PREGVIT TABLET

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

BETA-CAROTENE; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE); MAGNESIUM (MAGNESIUM OXIDE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); COPPER (CUPRIC OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)

Available from:

DUCHESNAY INC

ATC code:

B03AE04

INN (International Name):

IRON, MULTIVITAMINS AND MINERALS

Dosage:

1.6MG; 13.8MG; 120MG; 3MG; 3.4MG; 20MG; 10MG; 5MG; 50MG; 0.15MG; 35MG; 2MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG

Pharmaceutical form:

TABLET

Composition:

BETA-CAROTENE 1.6MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; COPPER (CUPRIC OXIDE) 2MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG

Administration route:

ORAL

Units in package:

30 PINK AND 30 BLUE TABLETS

Prescription type:

Prescription

Therapeutic area:

VITAMINS & MINERALS

Product summary:

Active ingredient group (AIG) number: 1747661005; AHFS:

Authorization status:

APPROVED

Authorization date:

2016-01-26

Summary of Product characteristics

_ _
_Pregvit_
_®_
_ and Pregvit_
_®_
_ folic 5Product Monograph _
_Page 1 of 39 _
_ _
PRODUCT MONOGRAPH
Pr
PREGVIT
®
Vitamin-Mineral Supplement Tablets
For Prenatal/Postpartum Use
Pr
PREGVIT
® FOLIC 5
Vitamin-Mineral Supplement Tablets
High Dose Folic Acid for Prenatal Use
Multivitamins and other Minerals Including Combinations
Duchesnay Inc.
950 boul. Michèle-Bohec
Blainville, Québec
Canada, J7C 5E2
www.duchesnay.com
© 2015 Duchesnay Inc.
Duchesnay Inc.
Patents: Canada 2,478,163; 2,478,278
(Other Patents Pending Worldwide)
Date of Revision:
January 26, 2016
Control No.: 183056
_ _
_Pregvit_
_®_
_ and Pregvit_
_®_
_ folic 5Product Monograph _
_Page 2 of 39 _
_ _
_ _
_ _
_Pregvit_
_®_
_ and Pregvit_
_®_
_ folic 5Product Monograph _
_Page 3 of 39 _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 4
SUMMARY PRODUCT INFORMATION
..............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
5
CONTRAINDICATIONS
.........................................................................................................................................
6
WARNINGS AND PRECAUTIONS
........................................................................................................................
6
ADVERSE REACTIONS
.........................................................................................................................................
8
DRUG INTERACTIONS
........................................................................................................................................
11
DOSAGE AND ADMINISTRATION
....................................................................................................................
16
OVERDOSAGE
..................................................................